You have selected the view in French
Descriptor English: | Anistreplase | ||||||
Descriptor Spanish: |
Anistreplasa
| ||||||
Descriptor Portuguese: | Anistreplase | ||||||
Descriptor French: | Anistreplase | ||||||
Entry term(s): |
APSAC BRL-26921 Complexe activateur plasminogène-streptokinase anisoylé |
||||||
Tree number(s): |
D08.811.277.656.300.760.635.075 D08.811.277.656.300.775.075 D08.811.277.656.959.350.635.075 D12.776.124.125.662.537.075 |
||||||
RDF Unique Identifier: | https://id.nlm.nih.gov/mesh/D016255 | ||||||
Scope note: | An acylated inactive complex of streptokinase and human lysine-plasminogen. After injection, the acyl group is slowly hydrolyzed, producing an activator that converts plasminogen to plasmin, thereby initiating fibrinolysis. Its half-life is about 90 minutes compared to 5 minutes for TPA; (TISSUE PLASMINOGEN ACTIVATOR); 16 minutes for UROKINASE-TYPE PLASMINOGEN ACTIVATOR and 23 minutes for STREPTOKINASE. If treatment is initiated within 3 hours of onset of symptoms for acute myocardial infarction, the drug preserves myocardial tissue and left ventricular function and increases coronary artery patency. Bleeding complications are similar to other thrombolytic agents. |
||||||
Allowable Qualifiers: |
AD administration et posologie AE effets indésirables AI antagonistes et inhibiteurs AN analyse BI biosynthèse BL sang CF liquide cérébrospinal CH composition chimique CL classification CS synthèse chimique DE effets des médicaments et des substances chimiques DF déficit EC économie GE génétique HI histoire IM immunologie IP isolement et purification ME métabolisme PD pharmacologie PH physiologie PK pharmacocinétique PO intoxication RE effets des radiations SD ressources et distribution ST normes TO toxicité TU usage thérapeutique UL ultrastructure UR urine |
||||||
Pharm Action: |
Fibrinolytic Agents |
||||||
Registry Number: | 81669-57-0 | ||||||
CAS Type 1 Name: | Anistreplase | ||||||
DeCS ID: | 28860 | ||||||
Unique ID: | D016255 | ||||||
Documents indexed in the Virtual Health Library (VHL): | Click here to access the VHL documents | ||||||
Date Established: | 1991/01/01 | ||||||
Date of Entry: | 1990/05/07 | ||||||
Revision Date: | 2016/07/01 |
-
-
PRODUITS CHIMIQUES ET PHARMACEUTIQUES
Enzymes et coenzymes [D08]Enzymes et coenzymes -
PRODUITS CHIMIQUES ET PHARMACEUTIQUES
Enzymes et coenzymes [D08]Enzymes et coenzymes -
PRODUITS CHIMIQUES ET PHARMACEUTIQUES
Enzymes et coenzymes [D08]Enzymes et coenzymes -
PRODUITS CHIMIQUES ET PHARMACEUTIQUES
Acides aminés, peptides et protéines [D12]Acides aminés, peptides et protéines
|
Anistreplase
- Preferred
BRL-26921
- Narrower
Concept UI |
M0024829 |
Preferred term | Anistreplase |
Entry term(s) |
APSAC Complexe activateur plasminogène-streptokinase anisoylé |
Concept UI |
M0333009 |
Preferred term | BRL-26921 |
We want your feedback on the new DeCS / MeSH website
We invite you to complete a survey that will take no more than 3 minutes.
Go to survey